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Background
With the introduction of newer atypical anti-psychotic
agents, a question emerged, concerning their use as com-
plementary pharmacotherapy or even as monotherapy in
mental disorders other than psychosis.
Material and Methods
MEDLINE was searched with the combination of each one
of the key words: risperidone, olanzapine and quetiapine
with key words that refered to every DSM-IV diagnosis
other than schizophrenia and other psychotic disorders,
bipolar disorder and dementia and memory disorders. All
papers were scored on the basis of the JADAD index.
Results
The search returned 483 papers. The selection process
restricted the sample to 59 papers concerning Risperi-
done, 37 concerning Olanzapine and 4 concerning
Quetiapine (100 in total). Ten papers (7 concerning Risp-
eridone and 3 concerning Olanzapine) had JADAD index
above 2. Data suggest that further research would be of
value concerning the use of risperidone in the treatment
of refractory OCD, Pervasive Developmental disorder,
stuttering and Tourette's syndrome, and the use of olanza-
pine for the treatment of refractory depression and bor-
derline personality disorder.
Discussion
Data on the off-label usefulness of newer atypical antipsy-
chotics are limited, but positive cues suggest that further
research may provide with sufficient hard data to warrant
the use of these agents in a broad spectrum of psychiatric
disorders, either as monotherapy, or as an augmentation
strategy.
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